Featured Research

from universities, journals, and other organizations

Antibody research paves way for new, more effective influenza drugs

Date:
August 19, 2014
Source:
Hebrew University of Jerusalem
Summary:
Research toward developing new antibodies could pave the way for more effective drugs to combat influenza infection. Influenza is a major global health problem. Annual epidemics of seasonal influenza cause approximately three to five million cases of severe illness, leading to between 250,000 and 500,000 deaths worldwide.

Diagram illustrating innovative process that could lead to more effective drugs against influenza infection. (Image courtesy Yotam Bar-On and Prof. Ofer Mandelboim)
Credit: Image courtesy of Hebrew University of Jerusalem

Research toward developing new antibodies at the Hebrew University of Jerusalem's Faculty of Medicine could pave the way for more effective drugs to combat influenza infection.

Related Articles


Influenza is a major global health problem. Annual epidemics of seasonal influenza cause approximately three to five million cases of severe illness, leading to between 250,000 and 500,000 deaths worldwide. In the United States, seasonal influenza epidemics are estimated to account for 3.1 million hospitalization days and an average of $10.4 billion loss in direct medical costs. "It is thus urgent to develop new drugs for fighting influenza infection, which requires an understanding of the virus's life cycle and its interaction with the host's immune system," said Yotam Bar-On, a Hebrew University Ph.D. candidate in immunology and cancer research.

Bar-On conducted his research under the tutelage of Prof. Ofer Mandelboim of the Lautenberg Center for General and Tumor Immunology, at the Institute for Medical Research Israel-Canada in the Hebrew University's Faculty of Medicine. The research earned Bar-On a Kaye Innovation Award, which was presented on June 11 in conjunction with the 77th annual meeting of the Hebrew University's Board of Governors.

In the past, says Bar-On, it was demonstrated that natural killer (NK) cells that belong to the body's innate immune system can eliminate influenza virus-infected cells. This is made possible via by one of the major NK killing receptors, NKp46, that recognizes influenza virus expressed on the infected cells.

A problem arises, however, in that the influenza viruses have a novel immune evasion mechanism that is mediated by the neuraminidase (NA) protein. NA counterattacks NKp46 recognition of infected cells and reduces its ability to eliminate them.

Bar-On's research has shown, for the first time, that NA inhibitors (which are already commonly used to treat influenza infections) enhance the NKp46-mediated killing of infected cells. Through further research into peptide components of the NA protein, Bar-On was able to develop antibodies that can to bind the NA, in effect "tying them up" and taking them out of action.

Bar-On's work has been patented through the Hebrew University's technology transfer company, Yissum, which is seeking commercial partners to continue research and development.

Bar-On is currently working on generating cross-reactive, anti-influenza antibodies that will bind the NA proteins in most of the influenza virus strains known today. He has shown that when injected into mice infected with influenza virus, these antibodies significantly improved their survival.

Bar-On's work is expected to make possible future new and more efficient drugs that will both target NA and at the same time more efficiently boost the NKp46-mediated killing of influenza virus. "Altogether, the novel antibodies we have developed will allow our immune system to respond more efficiently to a wide variety of influenza infections," concludes Bar-On.

The Kaye Innovation Awards at the Hebrew University have been awarded annually since 1994. Isaac Kaye of England, a prominent industrialist in the pharmaceutical industry, established the awards to encourage faculty, staff, and students of the Hebrew University to develop innovative methods and inventions with good commercial potential which will benefit the university and society.


Story Source:

The above story is based on materials provided by Hebrew University of Jerusalem. Note: Materials may be edited for content and length.


Cite This Page:

Hebrew University of Jerusalem. "Antibody research paves way for new, more effective influenza drugs." ScienceDaily. ScienceDaily, 19 August 2014. <www.sciencedaily.com/releases/2014/08/140819112925.htm>.
Hebrew University of Jerusalem. (2014, August 19). Antibody research paves way for new, more effective influenza drugs. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/2014/08/140819112925.htm
Hebrew University of Jerusalem. "Antibody research paves way for new, more effective influenza drugs." ScienceDaily. www.sciencedaily.com/releases/2014/08/140819112925.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Winter Can Cause Depression — Here's How To Combat It

Winter Can Cause Depression — Here's How To Combat It

Newsy (Nov. 23, 2014) Millions of American suffer from seasonal depression every year. It can lead to adverse health effects, but there are ways to ease symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins